Reaction
Device Alarm Issue reporting signals
As of the last recalculation, Device Alarm Issue appears in 1,780 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 299.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 282 | 299.1 | 305.7 |
| Carbidopa And Levodopa | 186 | 51.1 | 51.3 |
| Macitentan | 222 | 42.7 | 42.8 |
| Treprostinil | 346 | 39.8 | 39.9 |
| Ketoprofen | 37 | 33.7 | 33.7 |
| Bupivacaine | 23 | 29.1 | 29.2 |
| 0Xygen | 114 | 28.8 | 28.9 |
| Oxygen | 114 | 28.8 | 28.9 |
| Sildenafil | 127 | 27.5 | 27.6 |
| Pegfilgrastim | 206 | 27.5 | 27.5 |
| Riociguat | 73 | 27.3 | 27.3 |
| Amitriptyline Hydrochloride | 37 | 25.2 | 25.2 |
| Fremanezumab-Vfrm | 24 | 24.8 | 24.8 |
| Tadalafil | 190 | 24.7 | 24.8 |
| Sildenafil Powder, | 72 | 24.6 | 24.7 |
| Sildenafil Citrate | 219 | 22.8 | 22.8 |
| Rasagiline Mesylate | 19 | 20.2 | 20.2 |
| Rivastigmine | 31 | 19.6 | 19.6 |
| Amantadine | 25 | 19.2 | 19.2 |
| Baclofen | 125 | 18.2 | 18.2 |
| Pramipexole | 23 | 17.8 | 17.8 |
| Ambrisentan | 171 | 17.6 | 17.6 |
| Rotigotine | 19 | 15.5 | 15.5 |
| Clonidine | 58 | 13.7 | 13.7 |
| Cetirizine Hcl | 10 | 12.8 | 12.8 |
| Sodium Chloride Tablet | 75 | 12.4 | 12.4 |
| Sodium Chloride Tablets | 75 | 12.4 | 12.4 |
| Bosentan | 52 | 12.4 | 12.4 |
| Norepinephrine Bitartrate | 15 | 12.3 | 12.3 |
| Sodium Chloride | 78 | 12.0 | 12.0 |
| Memantine | 13 | 11.2 | 11.2 |
| Memantine Hydrochloride | 13 | 11.2 | 11.2 |
| Lidocaine Hydrochloride | 53 | 10.6 | 10.6 |
| Levodopa | 9 | 8.7 | 8.8 |
| Bumetanide | 18 | 8.0 | 8.0 |
| Selexipag | 16 | 7.3 | 7.3 |
| Benzonatate | 9 | 6.4 | 6.4 |
| Risankizumab-Rzaa | 38 | 5.5 | 5.5 |
| Norepinephrine | 5 | 5.5 | 5.5 |
| Droxidopa | 6 | 3.3 | 3.3 |
| Pimavanserin Tartrate | 13 | 2.8 | 2.8 |